These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 19699156

  • 1. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF, Banerjee S, Brabant Y, Helmers S.
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [Abstract] [Full Text] [Related]

  • 2. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 3. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 4. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.
    Eur Neurol; 2009 Jun 13; 61(4):233-9. PubMed ID: 19176965
    [Abstract] [Full Text] [Related]

  • 6. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Meyvisch P, Falter U.
    Epilepsia; 2007 Mar 13; 48(3):589-92. PubMed ID: 17326794
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S, Ceja H, Gawłowicz J, Avakyan G, McShea C, Schiemann J, Lu S.
    Epilepsy Res; 2012 Aug 13; 101(1-2):92-102. PubMed ID: 22516508
    [Abstract] [Full Text] [Related]

  • 8. Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.
    Chung S, Ceja H, Gawłowicz J, McShea C, Schiemann J, Lu S.
    Epilepsy Res; 2016 Feb 13; 120():7-12. PubMed ID: 26716580
    [Abstract] [Full Text] [Related]

  • 9. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 13; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May 13; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan 13; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 12. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug 13; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 13. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D.
    Epilepsy Behav; 2008 Feb 13; 12(2):305-10. PubMed ID: 18024209
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ.
    Clin Ther; 2010 Oct 13; 32(11):1935-50. PubMed ID: 21095488
    [Abstract] [Full Text] [Related]

  • 15. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar 13; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan 13; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 17. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W, Connor KM, Davidson JR.
    J Psychopharmacol; 2005 Sep 13; 19(5):551-3. PubMed ID: 16166192
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A.
    Epilepsia; 2006 Jul 13; 47(7):1128-35. PubMed ID: 16886975
    [Abstract] [Full Text] [Related]

  • 19. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
    Snoeck E, Stockis A.
    Epilepsy Res; 2007 Mar 13; 73(3):284-91. PubMed ID: 17196793
    [Abstract] [Full Text] [Related]

  • 20. Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial.
    de la Loge C, Hunter SJ, Schiemann J, Yang H.
    Epilepsy Behav; 2010 Jul 13; 18(3):291-8. PubMed ID: 20547106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.